Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Helius Medical Tech Q3 EPS $(32.89) Beats $(50.50) Estimate, Sales $697.000K Beat $110.000K Estimate

Author: Benzinga Newsdesk | November 18, 2025 04:06pm
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(32.89) per share which beat the analyst consensus estimate of $(50.50) by 34.87 percent. This is a 95.57 percent increase over losses of $(742.50) per share from the same period last year. The company reported quarterly sales of $697.000 thousand which beat the analyst consensus estimate of $110.000 thousand by 533.64 percent. This is a 1.27K percent increase over sales of $51.000 thousand the same period last year.

Posted In: HSDT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist